Your browser doesn't support javascript.
loading
Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases.
Bonella, Francesco; Cottin, Vincent; Valenzuela, Claudia; Wijsenbeek, Marlies; Voss, Florian; Rohr, Klaus B; Stowasser, Susanne; Maher, Toby M.
Afiliação
  • Bonella F; Interstitial and Rare Lung Disease Unit, Pneumology Department, Ruhrlandklinik, Duisburg-Essen University, Essen, Germany. francesco.bonella@ruhrlandklinik.uk-essen.de.
  • Cottin V; National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, UMR 754, Lyon, France.
  • Valenzuela C; Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain.
  • Wijsenbeek M; Centre for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • Voss F; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
  • Rohr KB; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
  • Stowasser S; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
  • Maher TM; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Adv Ther ; 39(7): 3392-3402, 2022 07.
Article em En | MEDLINE | ID: mdl-35576048
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática / Indóis Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática / Indóis Idioma: En Ano de publicação: 2022 Tipo de documento: Article